-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HxhfiM1x90KJ2nooIDpX0BC9LX7GAWHQwuuvZ40QJvarmwFTbCsyriO18n9aqdW1 PfAQvups4339f2jf2RxnCw== 0001237899-10-000008.txt : 20100106 0001237899-10-000008.hdr.sgml : 20100106 20100106155148 ACCESSION NUMBER: 0001237899-10-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100104 FILED AS OF DATE: 20100106 DATE AS OF CHANGE: 20100106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GILMAN ALFRED G CENTRAL INDEX KEY: 0001225473 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 10511585 MAIL ADDRESS: STREET 1: DEPT OF PHARMACOLOGY K5 YUVER OF TEXAS STREET 2: 5323 HARRY HINES BLVD CITY: DALLAS STATE: TX ZIP: 75390 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2010-01-04 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001225473 GILMAN ALFRED G 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2009-11-17 5 G 0 1000 0 D 20475 D Common Stock 2009-11-17 5 G 0 1000 0 D 19475 D Common Stock 2009-12-21 5 G 0 1000 0 D 18475 D Common Stock 2009-12-21 5 G 0 1000 0 D 17475 D Common Stock 2009-12-21 5 G 0 1000 0 D 16475 D Common Stock 2009-12-21 5 G 0 1000 0 D 15475 D Common Stock 2009-12-21 5 G 0 1000 0 D 14475 D Common Stock 2009-12-21 5 G 0 1000 0 D 13475 D Common Stock 2009-12-21 5 G 0 1000 0 D 12475 D Common Stock 2009-12-21 5 G 0 1000 0 D 11475 D Non-Qualified Stock Option (right to buy) 24.41 2010-01-04 4 A 0 15000 A 2020-01-04 Common Stock 15000 15000 D The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case. By: /s/**Stuart Kolinski For: /s/**Alfred G. Gilman 2010-01-06 EX-24 2 bny13229_bny1agg.txt EDGAR SUPPORTING DOCUMENT POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Leonard Schleifer, , Beverly Dubs, Stuart Kolinski, Murray Goldberg, and Douglas McCorkle signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned in the undersigned's capacity as a director of Regeneron Pharmaceuticals, Inc. (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-act on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 9th day of September, 2005. **/s/Alfred G. Gilman --------------------- Signature Alfred G. Gilman ---------------- Print Name -----END PRIVACY-ENHANCED MESSAGE-----